As an example, CHEK2-related breast cancer susceptibility is associated with a penetrance rate lower than that reported for BRCA1/2, but IFs in CHEK2 may be just as actionable in terms of cancer screening and surveillance (see NCCN guidelines; www.nccn.org). Here, CHEK2 is linked to breast carcinoma.